Physician
Oncology
Dr. Issa F. Khouri, MD
|
|
Give Review
Issa Khouri works in the field of Oncology. Issa F. Khouri, MD is also published. He has 46 publications published. The lastest publication: "Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.' Issa F. Khouri accepts all Medicare patients.
Publications
- Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.
- Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning.
- Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hemato...
- Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease.
- Life After FCR: Outcomes of patients with chronic lymphocytic Leukemia who progress after frontline treatment with Fludarabine, Cyclophosphamide and Rituximab.
- BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic Leukemia/lymphoma: reduced myelosuppression and GVHD.
- Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen-Matched Unre...
- Double hit Lymphoma: the MD Anderson Cancer Center clinical experience.
- Allogeneic stem cell transplantation as initial salvage for patients with Acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.
- Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor Cell mobilization.
- Cytarabine, Ki-67, and SOX11 in patients with mantle cell Lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission.
- High-dose chemotherapy and Autologous Stem Cell Transplantation For Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
- Incidence and natural history of pure red Cell aplasia in major ABO-mismatched haematopoietic Cell transplantation.
- Dose intensification of Busulfan in the preparative regimen is associated with improved survival: A Phase I/II Controlled, Randomized Study.
- Allogeneic hematopoietic stem Cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case-control study.
- Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome.
- High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-Cell transplantation in patients with refractory lymphoid malignancies.
- Significance of Persistent Cytogenetic Abnormalities at Myeloablative Allogeneic Stem Cell Transplantation in First Complete Remission.
- Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplant.
- Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell...
- Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular Lymphoma: 12-year results.
- Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin Lymphoma: pre...
- Platelet Recovery Prior to Allogeneic Stem Cell Transplant Predicts Posttransplant Outcomes in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome.
- Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic Leukemia: Long-Term Follow-Up, Prognostic Factors, and Effect of Human...
- Steroid-Refractory Acute GVHD: Predictors and Outcomes.
- Reduced-intensity allogeneic hematopoietic stem Cell transplantation for relapsed multiple myeloma.
- Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem Cell transplantation ...
- Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell Lymphoma.
- Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem Cell transplantation for hematologic malignancies.
- Eight-year experience with allogeneic stem cell transplantation for relapsed follicular Lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide...
- Adult Henoch-schönlein purpura in a patient with myelodysplastic syndrome and a history of follicular Lymphoma.
- Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid Leukemia.
- HyperAcute GVHD: risk factors, outcomes, and clinical implications.
- Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor Cells: a novel blood Cell component for therapeutic va...
- Primary plasma cell Leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
- Reduced-intensity regimens in allogeneic stem-cell transplantation for non-hodgkin lymphoma and chronic lymphocytic Leukemia.
- Unrelated donor marrow transplantation for B-cell chronic lymphocytic Leukemia after using myeloablative conditioning: results from the Center for International Blood ...
- Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's Lymphomas.
- Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's Lymphoma whose disease has failed a prior autolo...
- Evaluation of peripheral blood involvement of mantle cell lymphoma by fluorescence in Situ hybridization in comparison with immunophenotypic and morphologic findings.
- Nonmyeloablative stem cell transplantation for Lymphoma.
- Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell Lymphoma in first disease remission: the prognostic value of beta2-mic...
- Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell Lymphoma.
- Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem Cell transp...
- Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor Cell mobilization.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Carcinoma in Situ
- Central Nervous System Lymphoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Texas Health Science Center -
Sapienza University of Rome
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1669571980 | |
| NPPES Provider LastName | KHOURI | |
| NPPES Provider FirstName | ISSA | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 854.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 1.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669571980 |
| Last Name Of The Provider | KHOURI |
| First Name Of The Provider | ISSA |
| View All |
Similar Doctors
|
|
Dr. Francesco Turturro, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sattva S. Neelapu, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sumit K. Subudhi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Giuseppe Fraschini, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rachna Shroff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott M. Lippman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Lajos Pusztai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Srdan Verstovsek, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Alessandra Ferrajoli, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Uzma Iqbal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paulo M. Hoff, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Karin Hahn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria A. Scouros, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Theodore F. Tenczynski, MD
This Doctor is OpenDoctor Recommended.
|